The King of Ozempic Is Scared as Hell

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Related Content

This test can reduce lung cancer deaths

The new frontier in predicting disease outbreaks

How CubeSats are changing space exploration

Leave a Comment